← Back to Search

Exercise Intensity for Stroke Rehabilitation

N/A
Recruiting
Led By Marc Roig, PhD
Research Sponsored by McGill University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Must not have
Stroke of non-cardiogenic origin or tumor
Significant disability as determined by modified Rankin scale score <2
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 weeks
Awards & highlights
No Placebo-Only Group

Summary

This trial compares two exercise programs, HIIT and MICT, for stroke survivors. HIIT involves short bursts of intense exercise, while MICT is continuous moderate exercise. The goal is to see which program better improves brain function and heart health. The study will also check if participants find HIIT enjoyable and motivating. High-intensity interval training (HIIT) has been shown to induce significant improvements in numerous physiological and health-related indices, often to a similar or superior extent compared to moderate-intensity continuous training (MICT).

Who is the study for?
This trial is for individuals who had their first stroke 6-60 months ago, can walk at least 10 meters (with or without help), and have a basic ability to follow instructions. It's not suitable for those with other serious health issues that make exercise unsafe, currently in another rehab program, or have pain worsened by exercise.
What is being tested?
The study compares two types of exercises over 12 weeks: Moderate-Intensity Continuous Training (MICT) and High-intensity Interval Training (HIIT). Both are done on a machine that works arms and legs. Researchers will check how these affect brain recovery, heart health, mood, motivation, and walking.
What are the potential side effects?
While the document doesn't list specific side effects, typical risks from moderate to high-intensity exercise may include muscle soreness, fatigue, shortness of breath during activity. The eligibility criteria suggest avoiding participants where exercise could lead to significant discomfort or risk.

Eligibility Criteria

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I have had a stroke not caused by heart issues or due to a tumor.
Select...
I have little to no disability from my condition.
Select...
I have a condition that stops me from being able to exercise.
Select...
My pain gets worse when I exercise.
Select...
My heart health is classified as high risk by the American Heart Association.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 weeks for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Cortico-spinal excitability
Secondary study objectives
Arterial stiffness
Cardiorespiratory fitness
Diastolic resting blood pressure
+4 more
Other study objectives
Enjoyment
Gait speed
Motivation
+2 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Group I: Moderate-intensity continuous trainingExperimental Treatment1 Intervention
Intensity will be determined using a combination of heart rate reserve (HRR, calculated as HRR= \[max HR - resting HR\] x \[% training\] + \[resting HR\]) and ratings of perceived exertion (RPE). The MICT protocol will be increased using a progression schedule previously used (initial intensity at 40% HRR (RPE=9-11), and progressed by 10% HRR every 4 weeks up to 60% HRR (RPE=13-14) will be maintained until the end of the intervention). A 3-minute warm-up and 2-minute cool-down will be performed at 30% HRR (RPE=9-11). The total duration of MICT, including warm-up and cool-down, will be 35 minutes.
Group II: High-intensity interval trainingExperimental Treatment1 Intervention
Intensity will be determined using a combination of heart rate reserve (HRR, calculated as HRR= \[max HR - resting HR\] x \[% training\] + \[resting HR\]) and ratings of perceived exertion (RPE). The protocol will involve 10 60-second intervals of high intensity interspersed with 9 60-second low-intensity intervals. The initial high intensity intervals will start at 80% of the HRR (RPE=14-17) and progress by 10% every 4 weeks. Low intensity intervals will be performed at 30% of HRR (RPE=9-11). Three-minute warm-up and 2-minute cool-down periods will be performed at 30% of HRR. Total HIIT time including warm-up and cool-down is 24 minutes.

Research Highlights

Information in this section is not a recommendation. We encourage patients to speak with their healthcare team when evaluating any treatment decision.
Mechanism Of Action
Side Effect Profile
Prior Approvals
Other Research
High-Intensity Interval Training (HIIT) and Moderate-Intensity Continuous Training (MICT) are common exercise treatments for stroke rehabilitation. These exercises work by promoting brain plasticity, which is the brain's ability to reorganize itself by forming new neural connections. This is crucial for stroke patients as it helps in the recovery of motor functions and cognitive abilities that may have been impaired. Additionally, both HIIT and MICT improve cardiovascular health by enhancing blood flow and reducing the risk of further cardiovascular events, which is vital for stroke patients to prevent recurrent strokes and improve overall health outcomes.

Find a Location

Who is running the clinical trial?

Ontario Stroke NetworkOTHER
6 Previous Clinical Trials
827 Total Patients Enrolled
5 Trials studying Stroke
327 Patients Enrolled for Stroke
McMaster UniversityOTHER
917 Previous Clinical Trials
2,615,269 Total Patients Enrolled
24 Trials studying Stroke
42,227 Patients Enrolled for Stroke
Jewish Rehabilitation HospitalOTHER
6 Previous Clinical Trials
730 Total Patients Enrolled
3 Trials studying Stroke
160 Patients Enrolled for Stroke

Media Library

12 weeks of High-intensity Interval Training Clinical Trial Eligibility Overview. Trial Name: NCT03614585 — N/A
Stroke Research Study Groups: High-intensity interval training, Moderate-intensity continuous training
Stroke Clinical Trial 2023: 12 weeks of High-intensity Interval Training Highlights & Side Effects. Trial Name: NCT03614585 — N/A
12 weeks of High-intensity Interval Training 2023 Treatment Timeline for Medical Study. Trial Name: NCT03614585 — N/A
~14 spots leftby Nov 2025